Testing effectiveness (Phase 2)Not Yet RecruitingNCT05993858
What this trial is testing
Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC
Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Therapy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 33